Identifying gaps in the locoregional management of early breast cancer: Highlights from the Kyoto consensus conference

Annals of Surgical Oncology

Volumn 18, Issue 10, 2011, Pages 2885-2892

  Toi, Masakazu ^a   Winer, Eric P ^b   Inamoto, Takashi ^c   Benson, John R ^d   Forbes, John F ^e   Mitsumori, Michihide ^a   Robertson, John F R ^f   Sasano, Hironobu ^g   Von Minckwitz, Gunter ^h   Yamauchi, Akira ^c   Klimberg, V Suzanne ⁱ  

^a KYOTO UNIVERSITY   (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Kitano Hospital   (Japan)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^g TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h GOETHE UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INDOCYANINE GREEN;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONSENSUS; DIAGNOSTIC ACCURACY; FAMILIAL CANCER; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; INTRAOPERATIVE PERIOD; LYMPHATIC SYSTEM; LYMPHEDEMA; MASTECTOMY; MEDICAL RESEARCH; NOMOGRAM; PARTIAL MASTECTOMY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PUBLICATION; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SYSTEMIC THERAPY;

EID: 80052744471     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1666-7     Document Type: Article

References (52)

1. I de Mascarel G Macgrogan M Deblet, et al. 2008 Distinction between isolated tumor cells and micrometastasis in breast cancer Cancer. 112 1672 1678 18286534 10.1002/cncr.23368 (Pubitemid 351551810)
2. R Yerushalmi R Woods PM Ravdin, et al. 2010 Ki67 in breast cancer: prognostic and predictive potential Lancet Oncol 11 174 183 20152769 10.1016/S1470-2045(09)70262-1 1:CAS:528:DC%2BC3cXhtlGgtbc%3D
3. D Clarke N Khonji R Mansel 2001 Sentinel node biopsy in breast cancer: ALMANC trial World J Surg. 25 819 822 11376421 10.1007/s00268-001-0011-x 1:STN:280:DC%2BD3M3ps12mtA%3D%3D (Pubitemid 32531933)
4. C Boneti S Korourian K Bland, et al. 2008 Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy J Am Coll Surg. 206 1038 1044 18471751 10.1016/j.jamcollsurg.2007.12.022
5. T Kitai T Inomoto M Miwa, et al. 2005 Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer Breast Cancer. 12 211 215 16110291 10.2325/jbcs.12.211
6. M Yi F Meric-Bernstam MI Ross, et al. 2008 How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer. 113 30 37 18457326 10.1002/cncr.23514 (Pubitemid 351976383)
7. DJ Dabbs R Johnson 2004 The optimal number of sentinel lymph nodes for focused pathologic examination Breast J. 10 186 189 15125742 10.1111/j.1075-122X.2004.21283.x (Pubitemid 38715732)
8. G Zavagno GL De Salvo F Bozza, et al. 2004 Number of metastatic sentinel lymph nodes as predictor of axillary involvement in patients with breast cancer Breast Cancer Res Treat. 86 171 179 15319569 10.1023/B:BREA.0000032985.28558.6d (Pubitemid 38988020)
9. E Barranger C Coutant A Flahault, et al. 2005 An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement Breast Cancer Res Treat. 91 113 119 15868438 10.1007/s10549-004-5781-z (Pubitemid 40684923)
10. JF Boileau A Easson JM Escallon, et al. 2008 Sentinel nodes in breast cancer: relevance of axillary level II nodes and optimal number of nodes that need to be removed Ann Surg Oncol. 15 1710 1716 18324442 10.1245/s10434-008- 9858-5
11. I Rubio F Pedreira I Roca, et al. 2008 Removal of all radioactive sentinel nodes in breast cancer improves the detection of positive sentinel nodes Clin Transl Oncol. 10 347 350 18558581 10.1007/s12094-008-0210-0 1:STN:280:DC%2BD1czpt1aiug%3D%3D
12. U Veronesi V Galimberti G Paganelli, et al. 2009 Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases Eur J Cancer. 45 1381 1388 19128957 10.1016/j.ejca.2008.11.041
13. R Layeequr Rahman E Siegel C Boneti, et al. 2009 Stage migration with sentinel node biopsy in breast cancer Am J Surg. 197 491 496 19178897 10.1016/j.amjsurg.2008.07.052
14. JR Benson GQ della Rovere Axilla Management Consensus Group 2007 Management of the axilla in women with breast cancer Lancet Oncol 8 331 348 17395107 10.1016/S1470-2045(07)70103-1 (Pubitemid 46464531)
15. EP Mamounas A Brown S Anderson, et al. 2005 Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol. 23 2694 2702 15837984 10.1200/JCO.2005.05.188 (Pubitemid 46179459)
16. M Intra N Rotmensz P Veronesi, et al. 2008 Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years Ann Surg. 247 315 319 18216539 10.1097/SLA.0b013e31815b446b (Pubitemid 351156776)
17. TB Julian SR Land V Fourchotte, et al. 2007 Is sentinel node biopsy necessary in conservatively treated DCIS? Ann Surg Oncol. 14 2202 2208 17534687 10.1245/s10434-007-9353-4 (Pubitemid 47174907)
18. A Katz BL Smith M Golshan, et al. 2008 Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer J Clin Oncol. 26 2093 2098 18445838 10.1200/JCO.2007.11.9479
19. M Morrow 2010 Trends in the surgical treatment of breast cancer Breast J 16 Suppl 1 17 19 10.1111/j.1524-4741.2010.00996.x
20. MS Sabel 2011 Surgical considerations in early-stage breast cancer: lessons learned and future directions Semin Radiat Oncol. 21 10 19 21134649 10.1016/j.semradonc.2010.08.002
21. B Fisher S Anderson J Bryant, et al. 2002 Twenty-year follow up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer N Eng J Med. 347 1233 1241 10.1056/NEJMoa022152 (Pubitemid 35176242)
22. M Clarke R Collins S Darby, et al. 2005 Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2087 2106 16360786 1:STN:280:DC%2BD2MnnsVSitA%3D%3D (Pubitemid 41797643)
23. PL Nguyen AG Taghian MS Katz, et al. 2008 Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy J Clin Oncol. 26 2373 2378 18413639 10.1200/JCO.2007.14.4287
24. EH Romond EA Perez J Bryant, et al. 2005 Trastruzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med. 353 1673 1684 16236738 10.1056/NEJMoa052122 1:CAS:528:DC%2BD2MXhtFansr3F (Pubitemid 41464706)
25. Y Komoike F Akiyama Y Iino, et al. 2006 Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases Cancer. 106 35 41 16333848 10.1002/cncr.21551 (Pubitemid 43032546)
26. MC Cheang SK Chia D Voduc, et al. 2009 Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer J Natl Cancer Inst. 101 736 750 19436038 10.1093/jnci/djp082 1:CAS:528:DC%2BD1MXmtlyit74%3D
27. M Fatouros G Baltoyiannis DH Roukos 2008 The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations Ann Surg Oncol. 15 21 33 17940826 10.1245/s10434-007-9612-4
28. D Ziogas DH Roukos 2009 Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice Ann Surg Oncol. 16 1771 1782 19322611 10.1245/s10434-009-0436-2
29. CA Garcia-Etienne M Barile OD Gentilini, et al. 2009 Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer? Ann Surg Oncol. 16 3380 3387 19649554 10.1245/s10434-009-0638-7
30. N Bijker P Meijnen JL Peters 2006 Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group J Clin Oncol. 24 3381 3387 16801628 10.1200/JCO.2006.06.1366 (Pubitemid 46638893)
31. GA Viani EJ Stefalo SL Afonso, et al. 2007 Breast-conserving surgery with or without radiotherapy in woman with ductal carcinoma in situ: a meta-analysis of randomized trials Radiation Oncol. 2 28 39 10.1186/1748-717X-2-28
32. KS Hughes LA Schnaper D Berry, et al. 2004 Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer N Engl J Med. 351 971 977 15342805 10.1056/NEJMoa040587 1:CAS:528:DC%2BD2cXnt12msrg%3D (Pubitemid 39166260)
33. C Dunne JP Burke M Morrow, et al. 2009 Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ J Clin Oncol. 27 1615 1620 19255332 10.1200/JCO.2008.17.5182
34. B Fisher J Dignam N Wolmark, et al. 1999 Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Lancet. 353 1993 2000 10376613 10.1016/S0140-6736(99)05036-9 1:CAS:528:DyaK1MXkt1Cnsrk%3D (Pubitemid 29271743)
35. B Fisher J Bryant JJ Dignam, et al. 2002 Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less J Clin Oncol. 20 4141 4149 12377957 10.1200/JCO.2002.11.101 1:CAS:528:DC%2BD38XnsFyqsLg%3D (Pubitemid 35191016)
36. AP Forrest HJ Stewart D Everington, et al. 1996 Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group Lancet. 348 708 713 8806289 10.1016/S0140-6736(96)02133-2 1:STN:280:DyaK28zpvF2isQ%3D%3D (Pubitemid 26302305)
37. AW Fyles DR McCready LA Manchul, et al. 2004 Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer N Engl J Med. 351 963 970 15342804 10.1056/NEJMoa040595 1:CAS:528: DC%2BD2cXnt12nu7Y%3D (Pubitemid 39166259)
38. M Lim JR Bellon R Gelman, et al. 2006 A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer Int J Radiat Oncol Biol Phys. 65 1149 1154 16750330 10.1016/j.ijrobp.2006.02. 006
39. M Kyndi FB Sorensen H Knudsen, et al. 2008 Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group J Clin Oncol. 26 1419 1426 18285604 10.1200/JCO.2007.14.5565 1:CAS:528: DC%2BD1cXkslKqs7c%3D
40. SD Saverio F Catena D Santini, et al. 2008 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up Breast Cancer Res Treat. 109 405 416 17687650 10.1007/s10549-007-9668-7 (Pubitemid 351692055)
41. SM Bentzen RK Agrawal EG Aird, et al. 2008 The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial Lancet. 371 1098 1107 18355913 10.1016/S0140-6736(08)60348-7 1:STN:280:DC%2BD1c3hvVClsw%3D%3D
42. T Whelan R MacKenzie J Julian, et al. 2002 Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer J Natl Cancer Inst. 94 1143 1150 12165639 (Pubitemid 34919051)
43. H Bartelink JC Horiot PM Poortmans, et al. 2007 Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial J Clin Oncol. 25 3259 3265 17577015 10.1200/JCO.2007.11. 4991 (Pubitemid 47325610)
44. SE McGuire AM Gonzalez-Angulo EH Huang, et al. 2007 Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy Int J Radiat Oncol Biol Phys. 68 1004 1009 17418973 10.1016/j.ijrobp.2007.01.023 (Pubitemid 47048565)
45. EH Huang SL Tucker EA Strom, et al. 2004 Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy J Clin Oncol. 22 4691 4699 15570071 10.1200/JCO.2004.11.129 (Pubitemid 41185078)
46. EA O'Flynn JC Morel J Gonzalez, et al. 2009 Prediction of the presence of invasive disease from the measurement of extent of malignant microcalcification on mammography and ductal carcinoma in situ grade at core biopsy Clin Radiol. 64 178 183 19103348 10.1016/j.crad.2008.08.007
47. M Colleoni V Bagnardi N Rotmensz, et al. 2009 A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer Ann Oncol. 20 1178 1184 19218304 10.1093/annonc/mdn747 1:STN:280:DC%2BD1MvivFWkug%3D%3D
48. KY Bilimoria DJ Bentrem NM Hansen, et al. 2009 Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer J Clin Oncol. 27 2946 2953 19364968 10.1200/JCO.2008.19.5750
49. KJ Van Zee DM Manasseh JL Bevilacqua, et al. 2003 A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol. 10 1140 1151 14654469 10.1245/ASO.2003.03.015 (Pubitemid 40486808)
50. AS Gur B Unal R Johnson, et al. 2009 Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy J Am Coll Surg. 208 229 235 19228534 10.1016/j.jamcollsurg.2008.10.029
51. C Amanti A Lombardi S Maggi, et al. 2009 Is complete axillary dissection necessary for all patients with positive findings on sentinel lymph node biopsy? Validation of a breast cancer nomogram for predicting the likelihood of a non-sentinel lymph node Tumori. 95 153 155 19579859
52. C Coutant C Olivier E Lambaudie, et al. 2009 Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study J Clin Oncol. 27 2800 2808 19349546 10.1200/JCO.2008.19.7418